Graphene-based neural platform earns breakthrough device status
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Inbrain Neuroelectronics’ neural platform for its…
Articles by Margarida Maia, PhD
Scientists ID important new mechanism in familial Parkinson’s
The findings of new research identifying the mechanism behind a familial form of Parkinson’s — one caused by a…
AI-powered hand test may be used to rate Parkinson’s severity
An online artificial intelligence (AI)-powered test where users tap their fingers in front of a webcam may ultimately help rate…
Neurons that drive forward movement charted in the zebrafish brain
Researchers have built a map of how neurons wire up in the zebrafish brain to propel forward and steer movement,…
Eye scans may spot Parkinson’s years before diagnosis
Eye scans may help identify who’s at risk of developing Parkinson’s several years before symptoms first become apparent and…
Oral small molecule WTX-A seen to prevent toxic clumps in early study
WTX-A, a small molecule in the pipeline of Wavebreak, was able to reduce the formation of toxic clumps of…
Oregon lab 1st to test 2 levodopa formulations using Koneksa’s toolkit
Researchers in Oregon will be the first to incorporate Koneksa’s digital tools in a Parkinson’s disease study comparing…
Headset used by concussed athletes may be of help in Parkinson’s
A headset developed by MindRhythm was able to pick up abnormal brain changes that outlasted by two weeks the…
MJFF grant will aid Stealth’s study of mitochondrial biomarkers
A grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will support a two-year preclinical study by…
MJFF, Quansys to develop immunoassays for Parkinson’s
Quansys Biosciences and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) are teaming up to develop tests…